TuHURA Biosciences, Inc. (HURA)
NASDAQ·Healthcare·Biotechnology
$2.15
-3.15%
Mkt Cap $141.14M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$0.12 | -$0.12 | +2.70% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.15 | -$0.14 | +6.67% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.14 | -$0.21 | -50.00% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.13 | -$0.15 | -15.38% | — | — |
| Q1 2025 Feb 26, 2025 | — | — | — | -$0.09 | -$8.39 | -9222.22% | — | — |
| Q4 2024 Nov 14, 2024 | $6.32M | — | — | -$0.10 | -$1.37 | -1270.00% | — | — |
| Q2 2024 Jun 30, 2024 | — | — | — | — | -$1.47 | — | — | — |
| Q2 2024 May 14, 2024 | $6.08M | — | — | -$8.75 | -$0.05 | +99.43% | — | — |
| Q4 2023 Dec 31, 2023 | $6.08M | — | — | -$4.90 | -$8.26 | -68.48% | — | — |
| Q3 2023 Sep 30, 2023 | $5.11M | — | — | -$36.92 | -$0.09 | +99.75% | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$68.99 | — | — | — |
| Q1 2023 Mar 31, 2023 | $4.91M | — | — | -$3.50 | -$389.54 | -11029.77% | — | — |
| Q4 2022 Dec 31, 2022 | $4.91M | — | — | -$110.25 | -$73.58 | +33.26% | — | — |
| Q3 2022 Sep 30, 2022 | $4.71M | — | — | — | -$109.87 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$145.43 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$190.79 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$212.51 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$304.56 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$359.85 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$396.66 | — | — | — |